Presenilin-mediated signal transduction

Physiology and Behavior

Volumn 92, Issue 1-2, 2007, Pages 93-97

  Cowburn, Richard F ^a   Popescu, Bogdan O ^a   Ankarcrona, Maria ^a   Dehvari, Nodi ^a   Cedazo Minguez, Angel ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Calcium; Presenilin; Signal transduction

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHOLINERGIC RECEPTOR; GAMMA SECRETASE; GLYCOGEN SYNTHASE KINASE 3BETA; NICASTRIN; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PRESENILIN 1; RYANODINE RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CONFOCAL MICROSCOPY; ENZYME ACTIVITY; GENE MUTATION; GENETIC TRANSFECTION; NEUROBLASTOMA CELL; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 34548543758     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2007.05.053     Document Type: Article

References (30)

1. Chen Q., and Schubert D. Presenilin-interacting proteins. Exp Rev Mol Med 22 (2002) 1-18
2. De Strooper B. Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron 38 (2003) 9-12
3. Haass C., and Steiner H. Alzheimer disease gamma-secretase: a complex story of GxGD-type presenilin proteases. Trends Cell Biol 12 (2002) 556-562
4. Wolfe M.S. The gamma-secretase complex: membrane-embedded proteolytic ensemble. Biochemistry 45 (2006) 7931-7939
5. Mattson M.P., Gary D.S., Chan S.L., and Duan W. Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease. Biochem Soc Symp 67 (2001) 151-162
6. Gouras G.K., Almeida C.G., and Takahashi R.H. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 26 (2005) 1235-1244
7. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (1992) 184-185
8. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81 (2001) 741-766
9. Koo E.H., and Kopan R. Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. Nat Med 10 (2004) S26-S33
10. Dermaut B., Kumar-Singh S., Engelborghs S., Theuns J., Rademakers R., Saerens J., et al. A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol 55 (2004) 617-626
11. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3 (2002) 862-872
12. Katayama T., Imaizumi K., Sato N., Miyoshi K., Kudo T., Hitomi J., et al. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat Cell Biol 1 (1999) 479-485
13. Hansson C.A., Frykman S., Farmery M.R., Tjernberg L.O., Nilsberth C., Pursglove S.E., et al. Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J Biol Chem 279 (2004) 51654-51660
14. Grimes C.A., and Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65 (2001) 391-426
15. Pei J.J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B., and Cowburn R.F. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58 (1999) 1010-1019
16. Baki L., Shioi J., Wen P., Shao Z., Schwarzman A., Gama-Sosa M., et al. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J. 23 (2004) 2586-2596
17. Buxbaum J.D., Choi E.K., Luo Y., Lilliehook C., Crowley A.C., et al. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat Med 4 (1998) 1177-1181
18. Pack-Chung E., Meyers M.B., Pettingell W.P., Moir R.D., Brownawell A.M., Cheng I., et al. Presenilin-mediated modulation of capacitative calcium entry. J Biol Chem 275 (2000) 14440-14445
19. Popescu B.O., and Ankarcrona M. Mechanisms of cell death in Alzheimer's disease: role of presenilins. J Alzheimer's Dis 6 (2004) 123-128
20. Leissring M.A., Murphy M.P., Mead T.R., Akbari Y., Sugarman M.C., Jannatipour M., et al. Proc Natl Acad Sci USA 99 (2002) 4697-4702
21. Leissring M.A., Akbari Y., Fanger C.M., Cahalan M.D., Mattson M.P., and LaFerla F.M. A physiologic signaling role for the gamma-secretase-derived intracellular fragment of APP. J Cell Biol 149 (2000) 793-798
22. Yoo A.S., Cheng I., Chung S., Grenfell T.Z., Lee H., Pack-Chung E., et al. Presenilin-mediated modulation of capacitative calcium entry. Neuron 27 (2002) 561-572
23. Smith I.F., Boyle J.P., Vaughan P.F., Pearson H.A., Cowburn R.F., and Peers C.S. Ca(2+) stores and capacitative Ca(2+) entry in human neuroblastoma (SH-SY5Y) cells expressing a familial Alzheimer's disease presenilin-1 mutation. Brain Res 949 (2002) 105-111
24. Guo Q., Furukawa K., Sopher B.L., Pham D.G., Xie J., Robinson N., et al. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. NeuroReport 8 (1996) 379-383
25. Chan S.L., Mayne M., Holden C.P., Geiger J.D., and Mattson M.P. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J Biol Chem 275 (2000) 18195-18200
26. Cedazo-Minguez A., Popescu B.O., Ankarcrona M., Nishimura T., and Cowburn R.F. The presenilin 1 deltaE9 mutation gives enhanced basal phospholipase C activity and a resultant increase in intracellular calcium concentrations. J Biol Chem 277 (2002) 36646-36655
27. Popescu B.O., Cedazo-Minguez A., Benedikz E., Nishimura T., Winblad B., Ankarcrona M., et al. Gamma-secretase activity of presenilin 1 regulates acetylcholine muscarinic receptor-mediated signal transduction. J Biol Chem 279 (2004) 6455-6464
28. 2+ release from intracellulat stores. Neurobiol Dis 15 (2004) 269-278
29. 2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia. Neurobiol Dis 18 (2005) 638-648
30. Zatti G., Burgo A., Giacomello M., Barbiero L., Ghidoni R., Sinigala G., et al. Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticululm and Golgi apparatus calcium levels. Cell Calcium 39 (2006) 539-550